Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

An Open Label Study to Evaluate the Safety and Efficacy of Mechlorethamine(MCH) 0.04% Formulation in Mycosis Fungoides
An Open Label Study to Evaluate the Safety and Efficacy of Nitrogen Mustard (Mechlorethamine - MCH) 0.04% Formulation in Patients With Stage I-IIA Mycosis Fungoides Who Have Completed 12 Months Treatment Without a Complete Response
Status: Enrolling
Updated:  8/7/2012
University of Wisconsin
mi
from
Madison, WI
An Open Label Study to Evaluate the Safety and Efficacy of Mechlorethamine(MCH) 0.04% Formulation in Mycosis Fungoides
An Open Label Study to Evaluate the Safety and Efficacy of Nitrogen Mustard (Mechlorethamine - MCH) 0.04% Formulation in Patients With Stage I-IIA Mycosis Fungoides Who Have Completed 12 Months Treatment Without a Complete Response
Status: Enrolling
Updated: 8/7/2012
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing
Prospective Collection of Female First-catch Urine, Vaginal Swab, Endocervical Swab, and Cervical Specimens for Testing With the APTIMA Trichomonas Vaginalis Assay
Status: Enrolling
Updated:  8/10/2012
University of Alabama at Birmingham
mi
from
Birmingham, AL
Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing
Prospective Collection of Female First-catch Urine, Vaginal Swab, Endocervical Swab, and Cervical Specimens for Testing With the APTIMA Trichomonas Vaginalis Assay
Status: Enrolling
Updated: 8/10/2012
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing
Prospective Collection of Female First-catch Urine, Vaginal Swab, Endocervical Swab, and Cervical Specimens for Testing With the APTIMA Trichomonas Vaginalis Assay
Status: Enrolling
Updated:  8/10/2012
Wishard Hospital - Indiana University School of Medicine
mi
from
Indianapolis, IN
Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing
Prospective Collection of Female First-catch Urine, Vaginal Swab, Endocervical Swab, and Cervical Specimens for Testing With the APTIMA Trichomonas Vaginalis Assay
Status: Enrolling
Updated: 8/10/2012
Wishard Hospital - Indiana University School of Medicine
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing
Prospective Collection of Female First-catch Urine, Vaginal Swab, Endocervical Swab, and Cervical Specimens for Testing With the APTIMA Trichomonas Vaginalis Assay
Status: Enrolling
Updated:  8/10/2012
Louisiana State University
mi
from
New Orleans, LA
Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing
Prospective Collection of Female First-catch Urine, Vaginal Swab, Endocervical Swab, and Cervical Specimens for Testing With the APTIMA Trichomonas Vaginalis Assay
Status: Enrolling
Updated: 8/10/2012
Louisiana State University
mi
from
New Orleans, LA
Click here to add this to my saved trials
Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing
Prospective Collection of Female First-catch Urine, Vaginal Swab, Endocervical Swab, and Cervical Specimens for Testing With the APTIMA Trichomonas Vaginalis Assay
Status: Enrolling
Updated:  8/10/2012
New England Center for Clinical Research
mi
from
Fall River, MA
Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing
Prospective Collection of Female First-catch Urine, Vaginal Swab, Endocervical Swab, and Cervical Specimens for Testing With the APTIMA Trichomonas Vaginalis Assay
Status: Enrolling
Updated: 8/10/2012
New England Center for Clinical Research
mi
from
Fall River, MA
Click here to add this to my saved trials
Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing
Prospective Collection of Female First-catch Urine, Vaginal Swab, Endocervical Swab, and Cervical Specimens for Testing With the APTIMA Trichomonas Vaginalis Assay
Status: Enrolling
Updated:  8/10/2012
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing
Prospective Collection of Female First-catch Urine, Vaginal Swab, Endocervical Swab, and Cervical Specimens for Testing With the APTIMA Trichomonas Vaginalis Assay
Status: Enrolling
Updated: 8/10/2012
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing
Prospective Collection of Female First-catch Urine, Vaginal Swab, Endocervical Swab, and Cervical Specimens for Testing With the APTIMA Trichomonas Vaginalis Assay
Status: Enrolling
Updated:  8/10/2012
Geneuity Clinical Research Services
mi
from
Maryville, TN
Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing
Prospective Collection of Female First-catch Urine, Vaginal Swab, Endocervical Swab, and Cervical Specimens for Testing With the APTIMA Trichomonas Vaginalis Assay
Status: Enrolling
Updated: 8/10/2012
Geneuity Clinical Research Services
mi
from
Maryville, TN
Click here to add this to my saved trials
Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing
Prospective Collection of Female First-catch Urine, Vaginal Swab, Endocervical Swab, and Cervical Specimens for Testing With the APTIMA Trichomonas Vaginalis Assay
Status: Enrolling
Updated:  8/10/2012
Planned Parenthood Gulf Coast
mi
from
Houston, TX
Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing
Prospective Collection of Female First-catch Urine, Vaginal Swab, Endocervical Swab, and Cervical Specimens for Testing With the APTIMA Trichomonas Vaginalis Assay
Status: Enrolling
Updated: 8/10/2012
Planned Parenthood Gulf Coast
mi
from
Houston, TX
Click here to add this to my saved trials
Effectiveness of Integrating Prenatal Care in Reducing HIV/STDs Among Young Pregnant Women
Integrating Prenatal Care to Reduce HIV/STDs Among Teens: A Translational Study
Status: Enrolling
Updated:  8/12/2012
Centering Pregnancy and Parenting Association
mi
from
Cheshire, CT
Effectiveness of Integrating Prenatal Care in Reducing HIV/STDs Among Young Pregnant Women
Integrating Prenatal Care to Reduce HIV/STDs Among Teens: A Translational Study
Status: Enrolling
Updated: 8/12/2012
Centering Pregnancy and Parenting Association
mi
from
Cheshire, CT
Click here to add this to my saved trials
Effectiveness of Integrating Prenatal Care in Reducing HIV/STDs Among Young Pregnant Women
Integrating Prenatal Care to Reduce HIV/STDs Among Teens: A Translational Study
Status: Enrolling
Updated:  8/12/2012
Yale University Connecticut Women's Health Project
mi
from
New Haven, CT
Effectiveness of Integrating Prenatal Care in Reducing HIV/STDs Among Young Pregnant Women
Integrating Prenatal Care to Reduce HIV/STDs Among Teens: A Translational Study
Status: Enrolling
Updated: 8/12/2012
Yale University Connecticut Women's Health Project
mi
from
New Haven, CT
Click here to add this to my saved trials
Effectiveness of Integrating Prenatal Care in Reducing HIV/STDs Among Young Pregnant Women
Integrating Prenatal Care to Reduce HIV/STDs Among Teens: A Translational Study
Status: Enrolling
Updated:  8/12/2012
Clinical Directors Network
mi
from
New York, NY
Effectiveness of Integrating Prenatal Care in Reducing HIV/STDs Among Young Pregnant Women
Integrating Prenatal Care to Reduce HIV/STDs Among Teens: A Translational Study
Status: Enrolling
Updated: 8/12/2012
Clinical Directors Network
mi
from
New York, NY
Click here to add this to my saved trials
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated:  8/15/2012
Clinical Research Facility
mi
from
La Jolla, CA
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated: 8/15/2012
Clinical Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated:  8/15/2012
Clinical Research Facility
mi
from
Denver, CO
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated: 8/15/2012
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated:  8/15/2012
Clinical Research Facility
mi
from
Newark, DE
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated: 8/15/2012
Clinical Research Facility
mi
from
Newark, DE
Click here to add this to my saved trials
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated:  8/15/2012
Clinical Research Facility
mi
from
Chicago, IL
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated: 8/15/2012
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated:  8/15/2012
Clinical Research Facility
mi
from
Kansas City, KA
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated: 8/15/2012
Clinical Research Facility
mi
from
Kansas City, KA
Click here to add this to my saved trials
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated:  8/15/2012
Clinical Research Facility
mi
from
Boston, MA
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated: 8/15/2012
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated:  8/15/2012
Clinical Research Facility
mi
from
Minneapolis, MN
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated: 8/15/2012
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated:  8/15/2012
Clinical Research Facility
mi
from
Stony Brook, NY
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated: 8/15/2012
Clinical Research Facility
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated:  8/15/2012
Clinical Research Facility
mi
from
Oklahoma City, OK
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated: 8/15/2012
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated:  8/15/2012
Clinical Research Facility
mi
from
Houston, TX
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated: 8/15/2012
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Effect of Probiotic on the Innate and Adaptive Host Response to Rhinovirus (EPIARR)
Effect of Probiotic on the Innate and Adaptive Host Response to Rhinovirus (EPIARR)
Status: Enrolling
Updated:  8/20/2012
University of Virginia
mi
from
Charlottesville, VA
Effect of Probiotic on the Innate and Adaptive Host Response to Rhinovirus (EPIARR)
Effect of Probiotic on the Innate and Adaptive Host Response to Rhinovirus (EPIARR)
Status: Enrolling
Updated: 8/20/2012
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Comparison of Bacterial Contamination Rates Between Isolation and Non-isolation Rooms
Comparison of Contamination Rates of Medication Storage Cabinets Between Isolation and Non-isolation Rooms With Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated:  8/20/2012
West Virginia University Hospitals Inc.
mi
from
Morgantown, WV
Comparison of Bacterial Contamination Rates Between Isolation and Non-isolation Rooms
Comparison of Contamination Rates of Medication Storage Cabinets Between Isolation and Non-isolation Rooms With Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated: 8/20/2012
West Virginia University Hospitals Inc.
mi
from
Morgantown, WV
Click here to add this to my saved trials
A Model for Implementation of Cervical Cancer Screening and HPV Vaccination the Emergency Department: a Pilot Study
A Model for the Implementation of the Cervical Cancer Screening and HPV Vaccination in the Emergency Department: a Pilot Study.
Status: Enrolling
Updated:  8/21/2012
Sentara Norfolk General Hospital
mi
from
Norfolk, VA
A Model for Implementation of Cervical Cancer Screening and HPV Vaccination the Emergency Department: a Pilot Study
A Model for the Implementation of the Cervical Cancer Screening and HPV Vaccination in the Emergency Department: a Pilot Study.
Status: Enrolling
Updated: 8/21/2012
Sentara Norfolk General Hospital
mi
from
Norfolk, VA
Click here to add this to my saved trials
Acute Cough Study In Children
A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Single-Dose, Pilot Study To Evaluate Efficacy Of Dextromethorphan Hydrobromide On Acute Cough In A Pediatric Population
Status: Enrolling
Updated:  8/21/2012
Concentrics Center for Research
mi
from
Indianapolis, IN
Acute Cough Study In Children
A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Single-Dose, Pilot Study To Evaluate Efficacy Of Dextromethorphan Hydrobromide On Acute Cough In A Pediatric Population
Status: Enrolling
Updated: 8/21/2012
Concentrics Center for Research
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Acute Cough Study In Children
A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Single-Dose, Pilot Study To Evaluate Efficacy Of Dextromethorphan Hydrobromide On Acute Cough In A Pediatric Population
Status: Enrolling
Updated:  8/21/2012
Cyn3rgy Research
mi
from
Gresham, OR
Acute Cough Study In Children
A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Single-Dose, Pilot Study To Evaluate Efficacy Of Dextromethorphan Hydrobromide On Acute Cough In A Pediatric Population
Status: Enrolling
Updated: 8/21/2012
Cyn3rgy Research
mi
from
Gresham, OR
Click here to add this to my saved trials
Acute Cough Study In Children
A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Single-Dose, Pilot Study To Evaluate Efficacy Of Dextromethorphan Hydrobromide On Acute Cough In A Pediatric Population
Status: Enrolling
Updated:  8/21/2012
DMI Research
mi
from
Pinellas, FL
Acute Cough Study In Children
A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Single-Dose, Pilot Study To Evaluate Efficacy Of Dextromethorphan Hydrobromide On Acute Cough In A Pediatric Population
Status: Enrolling
Updated: 8/21/2012
DMI Research
mi
from
Pinellas, FL
Click here to add this to my saved trials
Acute Cough Study In Children
A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Single-Dose, Pilot Study To Evaluate Efficacy Of Dextromethorphan Hydrobromide On Acute Cough In A Pediatric Population
Status: Enrolling
Updated:  8/21/2012
Clinical Research Associates Incorporated
mi
from
Nashville, TN
Acute Cough Study In Children
A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Single-Dose, Pilot Study To Evaluate Efficacy Of Dextromethorphan Hydrobromide On Acute Cough In A Pediatric Population
Status: Enrolling
Updated: 8/21/2012
Clinical Research Associates Incorporated
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C -GSK1322322 After an Intravenous and an Oral Dose
An Open Label, Non-Randomized, Single Dose, Two Period, Cross-Over, Mass Balance Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C -GSK1322322 Administered as a Single Intravenous and Single Oral Dose to Healthy Adult Male Subjects
Status: Enrolling
Updated:  8/23/2012
GSK Investigational Site
mi
from
Rochester, MN
A Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C -GSK1322322 After an Intravenous and an Oral Dose
An Open Label, Non-Randomized, Single Dose, Two Period, Cross-Over, Mass Balance Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C -GSK1322322 Administered as a Single Intravenous and Single Oral Dose to Healthy Adult Male Subjects
Status: Enrolling
Updated: 8/23/2012
GSK Investigational Site
mi
from
Rochester, MN
Click here to add this to my saved trials
Dose Study of Tuberculin Purified Protein Derivative (JHP/Dose)
Dose Comparison Study of Tuberculin Purified Protein Derivative (PPD)With Standard Tuberculin Purified Protein Derivative.
Status: Enrolling
Updated:  9/18/2012
University of Texas Health Science Center at Tyler
mi
from
Tyler, TX
Dose Study of Tuberculin Purified Protein Derivative (JHP/Dose)
Dose Comparison Study of Tuberculin Purified Protein Derivative (PPD)With Standard Tuberculin Purified Protein Derivative.
Status: Enrolling
Updated: 9/18/2012
University of Texas Health Science Center at Tyler
mi
from
Tyler, TX
Click here to add this to my saved trials
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated:  9/19/2012
University of Kentucky Chandler Medical Center
mi
from
Lexington, KY
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated: 9/19/2012
University of Kentucky Chandler Medical Center
mi
from
Lexington, KY
Click here to add this to my saved trials
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated:  9/19/2012
LSU Health Sciences Center
mi
from
Shreveport, LA
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated: 9/19/2012
LSU Health Sciences Center
mi
from
Shreveport, LA
Click here to add this to my saved trials
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated:  9/19/2012
University of Mississippi Medical Center
mi
from
Jackson, MI
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated: 9/19/2012
University of Mississippi Medical Center
mi
from
Jackson, MI
Click here to add this to my saved trials
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated:  9/19/2012
Washington University
mi
from
St. Louis, MO
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated: 9/19/2012
Washington University
mi
from
St. Louis, MO
Click here to add this to my saved trials
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated:  9/19/2012
Duke Medical Center
mi
from
Durham, NC
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated: 9/19/2012
Duke Medical Center
mi
from
Durham, NC
Click here to add this to my saved trials
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated:  9/19/2012
Vidant Health
mi
from
Greenville, NC
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated: 9/19/2012
Vidant Health
mi
from
Greenville, NC
Click here to add this to my saved trials
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated:  9/19/2012
St. Joseph Regional Health Center
mi
from
Bryan, TX
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated: 9/19/2012
St. Joseph Regional Health Center
mi
from
Bryan, TX
Click here to add this to my saved trials
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated:  9/19/2012
Harris Methodist Hospital
mi
from
Ft. Worth, TX
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated: 9/19/2012
Harris Methodist Hospital
mi
from
Ft. Worth, TX
Click here to add this to my saved trials
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated:  9/19/2012
Scott & White Hospital
mi
from
Temple, TX
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated: 9/19/2012
Scott & White Hospital
mi
from
Temple, TX
Click here to add this to my saved trials
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated:  9/19/2012
University of Virginia, Blue Ridge PC
mi
from
Charlottesville, VA
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated: 9/19/2012
University of Virginia, Blue Ridge PC
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated:  9/19/2012
Virginia Commonwealth University Richmond
mi
from
Richmond, VA
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated: 9/19/2012
Virginia Commonwealth University Richmond
mi
from
Richmond, VA
Click here to add this to my saved trials
Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in HIV Infected Patients
A Multicenter, Open-label Phase I/II Study to Evaluate Safety and Immunogenicity of MVA-BN® Smallpox Vaccine in HIV Infected Subjects (CD4 Counts >350 / µl) and Healthy Subjects With and Without Previous Smallpox Vaccination
Status: Enrolling
Updated:  9/27/2012
Indiana University School of Medicine
mi
from
Indianapolis, IN
Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in HIV Infected Patients
A Multicenter, Open-label Phase I/II Study to Evaluate Safety and Immunogenicity of MVA-BN® Smallpox Vaccine in HIV Infected Subjects (CD4 Counts >350 / µl) and Healthy Subjects With and Without Previous Smallpox Vaccination
Status: Enrolling
Updated: 9/27/2012
Indiana University School of Medicine
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in HIV Infected Patients
A Multicenter, Open-label Phase I/II Study to Evaluate Safety and Immunogenicity of MVA-BN® Smallpox Vaccine in HIV Infected Subjects (CD4 Counts >350 / µl) and Healthy Subjects With and Without Previous Smallpox Vaccination
Status: Enrolling
Updated:  9/27/2012
University of Kentucky Medical Center
mi
from
Lexington, KY
Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in HIV Infected Patients
A Multicenter, Open-label Phase I/II Study to Evaluate Safety and Immunogenicity of MVA-BN® Smallpox Vaccine in HIV Infected Subjects (CD4 Counts >350 / µl) and Healthy Subjects With and Without Previous Smallpox Vaccination
Status: Enrolling
Updated: 9/27/2012
University of Kentucky Medical Center
mi
from
Lexington, KY
Click here to add this to my saved trials
Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in HIV Infected Patients
A Multicenter, Open-label Phase I/II Study to Evaluate Safety and Immunogenicity of MVA-BN® Smallpox Vaccine in HIV Infected Subjects (CD4 Counts >350 / µl) and Healthy Subjects With and Without Previous Smallpox Vaccination
Status: Enrolling
Updated:  9/27/2012
Washington University School of Medicine
mi
from
St.Louis, MO
Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in HIV Infected Patients
A Multicenter, Open-label Phase I/II Study to Evaluate Safety and Immunogenicity of MVA-BN® Smallpox Vaccine in HIV Infected Subjects (CD4 Counts >350 / µl) and Healthy Subjects With and Without Previous Smallpox Vaccination
Status: Enrolling
Updated: 9/27/2012
Washington University School of Medicine
mi
from
St.Louis, MO
Click here to add this to my saved trials
Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in HIV Infected Patients
A Multicenter, Open-label Phase I/II Study to Evaluate Safety and Immunogenicity of MVA-BN® Smallpox Vaccine in HIV Infected Subjects (CD4 Counts >350 / µl) and Healthy Subjects With and Without Previous Smallpox Vaccination
Status: Enrolling
Updated:  9/27/2012
Univ of Pennsylvania
mi
from
Philadelphia, PA
Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in HIV Infected Patients
A Multicenter, Open-label Phase I/II Study to Evaluate Safety and Immunogenicity of MVA-BN® Smallpox Vaccine in HIV Infected Subjects (CD4 Counts >350 / µl) and Healthy Subjects With and Without Previous Smallpox Vaccination
Status: Enrolling
Updated: 9/27/2012
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in HIV Infected Patients
A Multicenter, Open-label Phase I/II Study to Evaluate Safety and Immunogenicity of MVA-BN® Smallpox Vaccine in HIV Infected Subjects (CD4 Counts >350 / µl) and Healthy Subjects With and Without Previous Smallpox Vaccination
Status: Enrolling
Updated:  9/27/2012
Vanderbilt AIDS Clinical Trials Center
mi
from
Nashville, TN
Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in HIV Infected Patients
A Multicenter, Open-label Phase I/II Study to Evaluate Safety and Immunogenicity of MVA-BN® Smallpox Vaccine in HIV Infected Subjects (CD4 Counts >350 / µl) and Healthy Subjects With and Without Previous Smallpox Vaccination
Status: Enrolling
Updated: 9/27/2012
Vanderbilt AIDS Clinical Trials Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Botswana TDF/FTC Oral HIV Prophylaxis Trial
Study of the Safety and Efficacy of Daily Oral Antiretroviral Use for the Prevention of HIV Infection in Heterosexually Active Young Adults in Botswana
Status: Enrolling
Updated:  10/1/2012
Centers for Disease Control and Prevention
mi
from
Atlanta, GA
Botswana TDF/FTC Oral HIV Prophylaxis Trial
Study of the Safety and Efficacy of Daily Oral Antiretroviral Use for the Prevention of HIV Infection in Heterosexually Active Young Adults in Botswana
Status: Enrolling
Updated: 10/1/2012
Centers for Disease Control and Prevention
mi
from
Atlanta, GA
Click here to add this to my saved trials
Botswana TDF/FTC Oral HIV Prophylaxis Trial
Study of the Safety and Efficacy of Daily Oral Antiretroviral Use for the Prevention of HIV Infection in Heterosexually Active Young Adults in Botswana
Status: Enrolling
Updated:  10/1/2012
BOTUSA HIV Prevention Research Unit
mi
from
Francistown and Gaborone,
Botswana TDF/FTC Oral HIV Prophylaxis Trial
Study of the Safety and Efficacy of Daily Oral Antiretroviral Use for the Prevention of HIV Infection in Heterosexually Active Young Adults in Botswana
Status: Enrolling
Updated: 10/1/2012
BOTUSA HIV Prevention Research Unit
mi
from
Francistown and Gaborone,
Click here to add this to my saved trials
Study of Cyclodextrin (SBECD) and Voriconazole Blood Concentrations During Continuous Dialysis
Evaluation of Sulfobutylether-ß-cyclodextrin Sodium (SBECD) Accumulation and Voriconazole Pharmacokinetics in Patients Undergoing Continuous Renal Replacement Therapy
Status: Enrolling
Updated:  10/1/2012
University of Colorado Hospital
mi
from
Denver, CO
Study of Cyclodextrin (SBECD) and Voriconazole Blood Concentrations During Continuous Dialysis
Evaluation of Sulfobutylether-ß-cyclodextrin Sodium (SBECD) Accumulation and Voriconazole Pharmacokinetics in Patients Undergoing Continuous Renal Replacement Therapy
Status: Enrolling
Updated: 10/1/2012
University of Colorado Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics of Intravenous RPX2003 (Biapenem) in Healthy Adult Subjects
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Ascending Single- and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics of Intravenous RPX2003 in Healthy Adult Subjects
Status: Enrolling
Updated:  10/4/2012
Celerion
mi
from
Tempe, AZ
Safety, Tolerability, Pharmacokinetics of Intravenous RPX2003 (Biapenem) in Healthy Adult Subjects
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Ascending Single- and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics of Intravenous RPX2003 in Healthy Adult Subjects
Status: Enrolling
Updated: 10/4/2012
Celerion
mi
from
Tempe, AZ
Click here to add this to my saved trials